TFF Pharmaceuticals board member Michael Patane resigns effective June 30, 2024

TFF Pharmaceuticals, Inc.

Michael Patane resigned from the Board of Directors, effective June 30, 2024.
No reason for the resignation was disclosed in the filing.
No successor or replacement board member has been announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Patane

Director

TFF Pharmaceuticals, Inc.

Effective: 2024-06-30
Filed: July 1, 2024, 7:59 PM ET

On June 26, 2024, Michael Patane tendered his resignation from our Board of Directors effective as of June 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Patane resigned as Director at TFF Pharmaceuticals, Inc..

Action: resigned
Role: Director

Exact text from the filing

On June 26, 2024, Michael Patane tendered his resignation from our Board of Directors effective as of June 30, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001213900-24-057380

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.